These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 28274845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antihypertensive activity and molecular interactions of irbesartan in complex with 2-hydroxypropyl-β-cyclodextrin.
    Leonis G, Christodoulou E, Ntountaniotis D, Chatziathanasiadou MV, Mavromoustakos T, Naziris N, Chountoulesi M, Demetzos C, Valsami G, Damalas DE, Tzakos AG, Thomaidis NS, Karageorgos V, Liapakis G.
    Chem Biol Drug Des; 2020 Jul; 96(1):668-683. PubMed ID: 32691965
    [Abstract] [Full Text] [Related]

  • 3. Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs.
    Zhang L, Zhu W, Lin Q, Han J, Jiang L, Zhang Y.
    Int J Nanomedicine; 2015 Jul; 10():3291-302. PubMed ID: 25995635
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin.
    Hirlekar R, Kadam V.
    AAPS PharmSciTech; 2009 Jul; 10(1):276-81. PubMed ID: 19283492
    [Abstract] [Full Text] [Related]

  • 7. Thermal properties of adamantanol derivatives and their beta-cyclodextrin complexes in phosphatidylcholine bilayers.
    Mavromoustakos T, Papadopoulos A, Theodoropoulou E, Dimitriou C, Antoniadou-Vyza E.
    Life Sci; 1998 Jul; 62(20):1901-10. PubMed ID: 9600331
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A DSC and FTIR spectroscopic study of the effects of the epimeric 4-cholesten-3-ols and 4-cholesten-3-one on the thermotropic phase behaviour and organization of dipalmitoylphosphatidylcholine bilayer membranes: comparison with their 5-cholesten analogues.
    Benesch MG, Mannock DA, Lewis RN, McElhaney RN.
    Chem Phys Lipids; 2014 Jan; 177():71-90. PubMed ID: 24296232
    [Abstract] [Full Text] [Related]

  • 10. Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism.
    Ntountaniotis D, Andreadelis I, Kellici TF, Karageorgos V, Leonis G, Christodoulou E, Kiriakidi S, Becker-Baldus J, Stylos EK, Chatziathanasiadou MV, Chatzigiannis CM, Damalas DE, Aksoydan B, Javornik U, Valsami G, Glaubitz C, Durdagi S, Thomaidis NS, Kolocouris A, Plavec J, Tzakos AG, Liapakis G, Mavromoustakos T.
    Mol Pharm; 2019 Mar 04; 16(3):1255-1271. PubMed ID: 30681344
    [Abstract] [Full Text] [Related]

  • 11. Imidazolium-Based Lipid Analogues and Their Interaction with Phosphatidylcholine Membranes.
    Wang D, de Jong DH, Rühling A, Lesch V, Shimizu K, Wulff S, Heuer A, Glorius F, Galla HJ.
    Langmuir; 2016 Dec 06; 32(48):12579-12592. PubMed ID: 27934518
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Losartan Interactions with 2-Hydroxypropyl-β-CD.
    Palli V, Leonis G, Zoupanou N, Georgiou N, Chountoulesi M, Naziris N, Tzeli D, Demetzos C, Valsami G, Marousis KD, Spyroulias GA, Mavromoustakos T.
    Molecules; 2022 Apr 08; 27(8):. PubMed ID: 35458617
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization.
    Dudhipala N, Ettireddy S, Youssef AAA, Puchchakayala G.
    Molecules; 2021 Dec 13; 26(24):. PubMed ID: 34946619
    [Abstract] [Full Text] [Related]

  • 17. Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients.
    Muankaew C, Jansook P, Stefánsson E, Loftsson T.
    Int J Pharm; 2014 Oct 20; 474(1-2):80-90. PubMed ID: 25128698
    [Abstract] [Full Text] [Related]

  • 18. Deformation behaviors of tolbutamide, hydroxypropyl-beta-cyclodextrin, and their dispersions.
    Suihko E, Poso A, Korhonen O, Gynther J, Ketolainen J, Paronen P.
    Pharm Res; 2000 Aug 20; 17(8):942-8. PubMed ID: 11028939
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.